1-6 of 6
David Perez-Callejo
Close
Sort by
Journal Articles

Glofitamab Monotherapy Provides Durable Responses after Fixed-Length Dosing in Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (pts)

Michael Dickinson, Carmelo Carlo-Stella, Franck Morschhauser, Krish Patel, Cyrus Khan, Nancy L. Bartlett, Gloria Iacoboni, Mark Hertzberg, Sirpa Leppä, Eric Van Den Neste, Monica Tani, Guillaume Cartron, Antonio Salar, David Perez-Callejo, Linda Lundberg, James Relf, Emma Clark, Kathryn Humphrey, Martin Hutchings
Journal: Blood
Blood (2021) 138 (Supplement 1): 2478.
https://doi.org/10.1182/blood-2021-146845
Published: 2021
Journal Articles

Development of a Predictive Model for Cytokine Release Syndrome to Inform Risk Stratification and CRS Management Following Immunotherapy

Krishna V. Komanduri, Anton Belousov, Michelle Byrtek, Antonia Kwan, David Perez-Callejo, Chi-Chung Li, David Carlile, Bruce McCall, Tina Nielsen, Emily C. Piccione
Journal: Blood
Blood (2021) 138 (Supplement 1): 1459.
https://doi.org/10.1182/blood-2021-147303
Published: 2021
Journal Articles

Glofitamab As Monotherapy and in Combination with Obinutuzumab Induces High Complete Response Rates in Patients (pts) with Multiple Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Franck Morschhauser, Carmelo Carlo-Stella, Michael Dickinson, Tycel Phillips, Roch Houot, Fritz Offner, Corinne Haioun, Paolo Corradini, Martin Hutchings, Anna Sureda, Joaquín Martínez-López, Tomasz Wrobel, Shang-Ju Wu, Linda Lundberg, Estefania Mulvihill, David Perez-Callejo, James Relf, Anesh Panchal, Kathryn Humphrey, Emmanuel Bachy
Journal: Blood
Blood (2021) 138 (Supplement 1): 128.
https://doi.org/10.1182/blood-2021-148778
Published: 2021
Journal Articles

Glofitamab Step-up Dosing Induces High Response Rates in Patients (pts) with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL), Most of Whom Had Failed Prior Bruton's Tyrosine Kinase Inhibitor (BTKi) Therapy

Tycel Phillips, Michael Dickinson, Franck Morschhauser, Emmanuel Bachy, Michael Crump, Marek Trněný, Nancy L. Bartlett, Jan Zaucha, Kathryn Humphrey, David Perez-Callejo, Linda Lundberg, James Relf, Audrey Filézac de L'Étang, David Carlile, Emma Clark, Carmelo Carlo-Stella
Journal: Blood
Blood (2021) 138 (Supplement 1): 130.
https://doi.org/10.1182/blood-2021-148949
Published: 2021
Journal Articles

Diffuse Large B Cell Lymphoma Genetic Classification By Targeted Sequencing and Associations with Immunochemotherapy-Treated Patients' Clinical Outcome

Lucia Pedrosa Perez, Ismael Fernández-Miranda, David Perez Callejo, Cristina Quero, Marta Rodriguez, Paloma Martin-Acosta, Sagrario Gomez, Julia González-Rincón, Adrian Santos, Carlos Tarin, Juan F. Garcia, Francisco R García-Arroyo, Antonio Rueda, Francisca I Camacho, Monica Garcia-Cosio, MD, Ana Heredero, Marta Llanos, Manuela Mollejo, Miguel Piris-Villaespesa, José Gómez Codina, MD, Natalia Yanguas-Casás, Antonio Sánchez, Miguel A. Piris, Mariano Provencio, Margarita Sanchez-Beato
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-141193
Published: 2020
Journal Articles

Glofitamab Step-up Dosing Induces High Response Rates in Patients with Hard-to-Treat Refractory or Relapsed Non-Hodgkin Lymphoma

Martin Hutchings, MD PhD, Carmelo Carlo-Stella, MD, Emmanuel Bachy, MD PhD, Fritz C. Offner, MD PhD, Franck Morschhauser, MD PhD, Michael Crump, Gloria Iacoboni, MD, Anna Sureda Balari, MD PhD, Joaquin Martinez-Lopez, MD, Linda Lundberg, Mark Dixon, David Perez Callejo, James Relf, David Carlile, Emily Piccione, Kathryn Humphrey, Michael Dickinson, DMed Sci
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–48.
https://doi.org/10.1182/blood-2020-136044
Published: 2020